FNY Investment Advisers’s Mural Oncology MURA Stock Holding History

FNY Investment Advisers’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-147,076	Closed	-$304K	–	1263
2025 Q3	$304K	Buy	147,076 +143,436	+3,941%	+$308K	0.1%	214
2025 Q2	$8K	Buy	3,640 +640	+21%	+$1.51K	﹤0.01%	691
2025 Q1	$3K	Sell	3,000 -12,000	-80%	-$43.8K	﹤0.01%	622
2024 Q4	$48K	Sell	15,000 -5,000	-25%	-$17.6K	0.02%	338
2024 Q3	$62K	Sell	20,000 -12,000	-38%	-$39.1K	0.03%	260
2024 Q2	$100K	Buy	32,000 +25,500	+392%	+$94K	0.07%	180
2024 Q1	$31	Hold	6,500	–	–	0.02%	318
2023 Q4	$38K	Buy	+6,500	New	+$26.1K	0.04%	212

FNY Investment Advisers's MURA Position: Q4 2025 in Review

FNY Investment Advisers sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 147,076 shares — an estimated $304K sold.

FNY Investment Advisers first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $304K in Q3 2025. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

FNY Investment Advisers reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
FNY Investment Advisers sold 147,076 Mural Oncology shares in Q4 2025, an estimated $304K.
FNY Investment Advisers first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
FNY Investment Advisers's Mural Oncology position peaked at $304K in Q3 2025.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.